DCR-A1AT

DCR-A1AT · Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DCR-A1AT, covering 2024-11-06 to 2024-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of DCR-A1AT in Healthy Adult Volunteers [Phase 1]